Concepedia

Paul E. Harrington

PE

Statistics

Publications

28

Citations

1.7K

H-Index

20

Active since

1997

Affiliations

Amgen (United States)(Current)

University of Hawaii System

Merck & Co., Inc., Rahway, NJ, USA (United States)

Stanford University

University of Hawaiʻi at Mānoa

Paul E. Harrington is an author at Amgen (United States) specializing in pharmacology, drug discovery, and medicine.

Top concepts

PharmacologyMedicineDrug DiscoveryMedicinal ChemistryBiochemistryNatural SciencesEngineeringPharmacotherapyOrganic ChemistryBiomolecular Engineering

Publications per year

1997–2014

28

Publications

28

Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)

Joey L. Methot, Prasun K. Chakravarty, Mélissa Chénard et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 185 citations · Full text

Histone Modifications, Chromatin, Medicinal Chemistry +10

Synthesis and Absolute Stereochemistry of Roseophilin

Paul E. Harrington, Marcus A. Tius · Journal of the American Chemical Society · 2001 · 143 citations

Medicinal Chemistry, Biosynthesis, Bioorganic Chemistry +14

Dinuclear Asymmetric Zn Aldol Additions: Formal Asymmetric Synthesis of Fostriecin

Barry M. Trost, Mathias Frederiksen, Julien P. N. Papillon et al. · Journal of the American Chemical Society · 2005 · 133 citations

Natural Product Synthesis, Formal Asymmetric Synthesis, Engineering +11

Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability

Paul E. Harrington, Kaustav Biswas, David J. Malwitz et al. · ACS Medicinal Chemistry Letters · 2014 · 103 citations · Full text

Cellular Viability, Kinase Site, Protein Response +20

Reaction of Indoles with Electron Deficient Olefins Catalyzed by Yb(OTf)<sub>3</sub>⋅3H<sub>2</sub>O

Paul E. Harrington, Michael A. Kerr · Synlett · 2000 · 103 citations

Hapalindole Class, Engineering, Biochemistry +11

1–5 of 28